Empagliflozin and Metformin Tablets 5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
MFDS item code 202201443 · Approved 2022.04.05
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It is particularly effective in adult patients who are suitable for dual therapy with empagliflozin and metformin. Furthermore, if adult patients with type 2 diabetes have not had sufficient blood sugar control, especially those with confirmed cardiovascular disease, it should be used with caution according to clinical trial information. This medication helps manage blood sugar effectively for diabetes treatment.
The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other drugs such as insulin, the recommended dose when taking this drug is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this drug from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this drug is coadministered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions in Precautions for Use). This drug should be taken with food to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this drug is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this drug contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily. Renal function should be closely monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function decreases to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this drug should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Receive This Drug, item 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication can cause a rare but serious side effect known as lactic acidosis, therefore it should not be used in patients with poor kidney function, acute kidney issues, severe infections, or dehydration. Additionally, the risk of hypoglycemia may increase if this medication is used in conjunction with insulin or sulfonylureas, so blood sugar levels should be monitored carefully in such cases. It is best to avoid this medication in pregnant women or those who may become pregnant, breastfeeding mothers, and patients with severely impaired liver function. Since this medication is influenced by kidney function, regular kidney function tests should be performed before and during treatment, and the medication should be discontinued if kidney function falls below a certain level. Before and after procedures utilizing iodinated contrast media, this medication should be temporarily discontinued, and resumed only after kidney function has returned to normal. This medication can lead to fluid loss, so it should be used carefully in elderly patients, those with low blood pressure, or symptoms of dehydration, with the option to interrupt treatment if necessary. During treatment, urinary tract infections or genital infections may occur, thus any infections should be reported to healthcare professionals immediately. Since vitamin B12 levels may decrease, it is advisable to check blood vitamin B12 levels in patients receiving long-term treatment. It is crucial to avoid alcohol consumption while taking this medication, and be cautious of irregular eating habits or excessive exercise, as well as potential interactions with other medications that may increase the risk of hypoglycemia or ketoacidosis. Elderly patients have a higher risk of renal function decline and fluid loss; therefore, dosage adjustments and regular monitoring are necessary during treatment. In the event of an overdose of this medication, it is essential to seek medical attention promptly, especially if symptoms of lactic acidosis occur, as immediate emergency treatment is required.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container, ensuring it does not come into contact with air or moisture, and keep it at a safe temperature between 1 degree and 30 degrees Celsius. Storing it this way can help maintain its efficacy for a longer duration.
Orange-yellow, bilaterally convex oval film-coated tablets
10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/box [(10 tablets/PTP x 6)], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.